CMML: decitabine shows efficacy, even in proliferative disease

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

Takeaway

  • Decitabine (Dacogen) demonstrated encouraging efficacy in patients with chronic myelomonocytic leukemia (CMML), including patients with proliferative disease.

Why this matters

  • CMML is associated with poor prognosis.
  • Hematopoietic stem cell transplant is currently the only ...